Distribution agreement for BioView’s early detection Lung Cancer Test was signed in Australia and New-Zealand

BioView is happy to announce that it has signed an agreement with Diagnostic Solutions (Australia) for the marketing of the LCD test developed for Australia and New-Zealand.

As part of the agreement, during the first phase DS will perform a validation trial at one of the most important hospitals in Sydney and in parallel DS will apply to the local authorities for obtaining TGA regulatory approval and reimbursement code. As a second phase DS will purchase and distribute BioView’s imaging system combined with the LCD test kits.

About Diagnostic Solutions:

Diagnostic Solutions was established in 1998 to meet the changing needs of the IVD Pathology Industry in Australia and New-Zealand, by providing leading edge laboratory testing technology supported by a highly trained and professional support and service team.

Diagnostic Solutions is part of Diploma Healthcare Group, which is owned by Diploma PLC, traded in London (DPLM:London).